| Overview |
| bsm-90280r-50µL |
| DGCR8 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human DGCR8 |
| 400-773/773 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 54487 |
| Q8WYQ5 |
| DGCR8; DGCR8 Microprocessor Complex Subunit; DGCRK6; DiGeorge Syndrome Critical Region Gene 8; Microprocessor Complex Subunit DGCR8; DiGeorge Syndrome Critical Region 8; C22orf12; Pasha; Gy1; DGCR8 Microprocessor Complex Subunit; Chromosome 22 Open Reading Frame 12; C22ORF12; PASHA; GY1 |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
Powered by Bioz